Pharmacy Practice
Affordable Medicines
Biosimilars
Compliance
Compounding
Drug Approvals
Geriatrics
Hospital/Health System
In-Pharmacy Vaccines
Law
Medication Management
News & Trends
OTC
Pharmacist Resources
Specialty Pharmacy
Technology
Disease State
Allergy
Autoimmune
Breast Cancer
Cardiovascular
Cold & Flu
COVID-19
Dermatology
Diabetes
Gastroenterology
Hematology
HIV/AIDS
Infectious Disease
Infusion
Lung Cancer
Mental Health
mRNA Technology
Neurology
Oncology
Ophthalmology
Orthopedics
Pain Management
Pediatrics
Respiratory
Schizophrenia
Urology/Nephrology
Women’s Health
Health Awareness Month
Videos
Patient Teaching Aid
Publications
Featured Issue
Featured Supplements
Conference Coverage
Continuing Education
Subscribe
COVID-19 Resources
mRNA Technology
December 6, 2022
Scientists Explore a 20-Subtype mRNA Influenza Vaccine
December 6, 2022
Pfizer-BioNTech’s Omicron Boosters Show Improved Immune Response
December 6, 2022
Moderna’s Booster Candidates Produced Superior Omicron Response
November 17, 2022
Updated Data for Pfizer-BioNTech Omicron BA.4/BA.5 Bivalent Booster
November 17, 2022
Investigational Cancer Vaccine Announced by Merck and Moderna
November 17, 2022
CDC Reports Safety Findings for Bivalent COVID-19 Vaccine Boosters
October 24, 2022
Positive Data From Trial of Omicron BA.4/BA.5–Adapted Bivalent Booster
October 24, 2022
Bivalent mRNA Vaccine Shows Superior Antibody Response
October 24, 2022
Bivalent COVID-19 Boosters Authorized for Younger Patients
September 22, 2022
COVID-19 Vaccine and Booster Use in Patients With Lupus
September 22, 2022
COVID-19 Vaccines Safe in Patients With Heart Failure
September 22, 2022
FDA Authorizes EUAs for Bivalent COVID-19 Vaccine Boosters
May 23, 2022
Atopic Dermatitis Immunosuppressive Drugs and Efficacy With COVID-19 Vaccine
Load More
X
May 2023
In This Issue
Digital Magazine
Archives
Subscription
×
Full Image